Paying users zone. Data is covered by hidden.

  • Get 1 month access to Regeneron Pharmaceuticals Inc. for $13.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Regeneron Pharmaceuticals Inc. (REGN)


Short-term (Operating) Activity Analysis

Difficulty: Beginner


Ratios (Summary)

Regeneron Pharmaceuticals Inc., short-term (operating) activity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Turnover Ratios
Inventory turnover hidden hidden hidden hidden hidden
Receivables turnover hidden hidden hidden hidden hidden
Payables turnover hidden hidden hidden hidden hidden
Working capital turnover hidden hidden hidden hidden hidden
Average No. of Days
Average inventory processing period hidden hidden hidden hidden hidden
Add: Average receivable collection period hidden hidden hidden hidden hidden
Operating cycle hidden hidden hidden hidden hidden
Less: Average payables payment period hidden hidden hidden hidden hidden
Cash conversion cycle hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

Ratio Description The company
Inventory turnover An activity ratio calculated as cost of goods sold divided by inventory. Regeneron Pharmaceuticals Inc.’s inventory turnover deteriorated from 2016 to 2017 and from 2017 to 2018.
Receivables turnover An activity ratio equal to revenue divided by receivables. Regeneron Pharmaceuticals Inc.’s receivables turnover deteriorated from 2016 to 2017 and from 2017 to 2018.
Payables turnover An activity ratio calculated as cost of goods sold divided by payables. Regeneron Pharmaceuticals Inc.’s payables turnover declined from 2016 to 2017 and from 2017 to 2018.
Working capital turnover An activity ratio calculated as revenue divided by working capital. Regeneron Pharmaceuticals Inc.’s working capital turnover deteriorated from 2016 to 2017 and from 2017 to 2018.

Ratio Description The company
Average inventory processing period An activity ratio equal to the number of days in the period divided by inventory turnover over the period. Regeneron Pharmaceuticals Inc.’s average inventory processing period deteriorated from 2016 to 2017 and from 2017 to 2018.
Average receivable collection period An activity ratio equal to the number of days in the period divided by receivables turnover. Regeneron Pharmaceuticals Inc.’s average receivable collection period deteriorated from 2016 to 2017 and from 2017 to 2018.
Operating cycle Equal to average inventory processing period plus average receivables collection period. Regeneron Pharmaceuticals Inc.’s operating cycle deteriorated from 2016 to 2017 and from 2017 to 2018.
Average payables payment period An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. Regeneron Pharmaceuticals Inc.’s average payables payment period increased from 2016 to 2017 and from 2017 to 2018.
Cash conversion cycle A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. Regeneron Pharmaceuticals Inc.’s cash conversion cycle deteriorated from 2016 to 2017 and from 2017 to 2018.

Inventory Turnover

Regeneron Pharmaceuticals Inc., inventory turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Cost of goods sold hidden hidden hidden hidden hidden
Inventories hidden hidden hidden hidden hidden
Ratio
Inventory turnover1 hidden hidden hidden hidden hidden
Benchmarks
Inventory Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Inventory Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Inventory Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Inventory turnover = Cost of goods sold ÷ Inventories
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Inventory turnover An activity ratio calculated as cost of goods sold divided by inventory. Regeneron Pharmaceuticals Inc.’s inventory turnover deteriorated from 2016 to 2017 and from 2017 to 2018.

Receivables Turnover

Regeneron Pharmaceuticals Inc., receivables turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Net product sales hidden hidden hidden hidden hidden
Accounts receivable, trade, net hidden hidden hidden hidden hidden
Ratio
Receivables turnover1 hidden hidden hidden hidden hidden
Benchmarks
Receivables Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Receivables Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Receivables Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Receivables turnover = Net product sales ÷ Accounts receivable, trade, net
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Receivables turnover An activity ratio equal to revenue divided by receivables. Regeneron Pharmaceuticals Inc.’s receivables turnover deteriorated from 2016 to 2017 and from 2017 to 2018.

Payables Turnover

Regeneron Pharmaceuticals Inc., payables turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Cost of goods sold hidden hidden hidden hidden hidden
Accounts payable hidden hidden hidden hidden hidden
Ratio
Payables turnover1 hidden hidden hidden hidden hidden
Benchmarks
Payables Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Payables Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Payables Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Payables turnover = Cost of goods sold ÷ Accounts payable
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Payables turnover An activity ratio calculated as cost of goods sold divided by payables. Regeneron Pharmaceuticals Inc.’s payables turnover declined from 2016 to 2017 and from 2017 to 2018.

Working Capital Turnover

Regeneron Pharmaceuticals Inc., working capital turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (USD $ in thousands)
Current assets hidden hidden hidden hidden hidden
Less: Current liabilities hidden hidden hidden hidden hidden
Working capital hidden hidden hidden hidden hidden
Net product sales hidden hidden hidden hidden hidden
Ratio
Working capital turnover1 hidden hidden hidden hidden hidden
Benchmarks
Working Capital Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Working Capital Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Working Capital Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Working capital turnover = Net product sales ÷ Working capital
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Working capital turnover An activity ratio calculated as revenue divided by working capital. Regeneron Pharmaceuticals Inc.’s working capital turnover deteriorated from 2016 to 2017 and from 2017 to 2018.

Average Inventory Processing Period

Regeneron Pharmaceuticals Inc., average inventory processing period calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data
Inventory turnover hidden hidden hidden hidden hidden
Ratio (no. of days)
Average inventory processing period1 hidden hidden hidden hidden hidden
Benchmarks (no. of days)
Average Inventory Processing Period, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Average Inventory Processing Period, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Average Inventory Processing Period, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Average inventory processing period An activity ratio equal to the number of days in the period divided by inventory turnover over the period. Regeneron Pharmaceuticals Inc.’s average inventory processing period deteriorated from 2016 to 2017 and from 2017 to 2018.

Average Receivable Collection Period

Regeneron Pharmaceuticals Inc., average receivable collection period calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data
Receivables turnover hidden hidden hidden hidden hidden
Ratio (no. of days)
Average receivable collection period1 hidden hidden hidden hidden hidden
Benchmarks (no. of days)
Average Receivable Collection Period, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Average Receivable Collection Period, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Average Receivable Collection Period, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Average receivable collection period An activity ratio equal to the number of days in the period divided by receivables turnover. Regeneron Pharmaceuticals Inc.’s average receivable collection period deteriorated from 2016 to 2017 and from 2017 to 2018.

Operating Cycle

Regeneron Pharmaceuticals Inc., operating cycle calculation, comparison to benchmarks

No. of days

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data
Average inventory processing period hidden hidden hidden hidden hidden
Average receivable collection period hidden hidden hidden hidden hidden
Ratio
Operating cycle1 hidden hidden hidden hidden hidden
Benchmarks
Operating Cycle, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Operating Cycle, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Operating Cycle, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= hidden + hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Operating cycle Equal to average inventory processing period plus average receivables collection period. Regeneron Pharmaceuticals Inc.’s operating cycle deteriorated from 2016 to 2017 and from 2017 to 2018.

Average Payables Payment Period

Regeneron Pharmaceuticals Inc., average payables payment period calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data
Payables turnover hidden hidden hidden hidden hidden
Ratio (no. of days)
Average payables payment period1 hidden hidden hidden hidden hidden
Benchmarks (no. of days)
Average Payables Payment Period, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Average Payables Payment Period, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Average Payables Payment Period, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Average payables payment period An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. Regeneron Pharmaceuticals Inc.’s average payables payment period increased from 2016 to 2017 and from 2017 to 2018.

Cash Conversion Cycle

Regeneron Pharmaceuticals Inc., cash conversion cycle calculation, comparison to benchmarks

No. of days

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data
Average inventory processing period hidden hidden hidden hidden hidden
Average receivable collection period hidden hidden hidden hidden hidden
Average payables payment period hidden hidden hidden hidden hidden
Ratio
Cash conversion cycle1 hidden hidden hidden hidden hidden
Benchmarks
Cash Conversion Cycle, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Cash Conversion Cycle, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Cash Conversion Cycle, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= hidden + hiddenhidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Cash conversion cycle A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. Regeneron Pharmaceuticals Inc.’s cash conversion cycle deteriorated from 2016 to 2017 and from 2017 to 2018.